CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,307,135
- in 1 filing, $6.3M under 10b5-1 plans
Net −$6,307,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-10 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Shares withheld for taxes 10b5-1 | −876 | $467.98 | $410K | 24,972 |
| 2025-02-10 | Arbuckle Stuart A EVP, COO | Shares withheld for taxes | −3,220 | $467.98 | $1.5M | 69,543 |
| 2025-02-10 | Ambrose Kristen SVP & Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −591 | $467.98 | $277K | 11,329 |
| 2025-02-10 | ALTSHULER DAVID EVP, Chief Scientific Officer | Shares withheld for taxes | −2,142 | $467.98 | $1.0M | 43,099 |
| 2025-02-04 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Grant or award | +10,262 | 54,414 | ||
| 2025-02-04 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Grant or award | +7,114 | 61,528 | ||
| 2025-02-04 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Grant or award | +10,262 | 59,360 | ||
| 2025-02-04 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Grant or award | +7,114 | 66,474 | ||
| 2025-02-04 | Sachdev Amit EVP Chief Patient & Ext Af Off | Grant or award | +8,210 | 65,533 | ||
| 2025-02-04 | Sachdev Amit EVP Chief Patient & Ext Af Off | Grant or award | +7,114 | 72,647 | ||
| 2025-02-04 | LEIDEN JEFFREY M Executive Chairman | Grant or award | +15,414 | 25,408 | ||
| 2025-02-04 | Kewalramani Reshma CEO & President | Grant or award | +29,118 | 104,890 | ||
| 2025-02-04 | Kewalramani Reshma CEO & President | Grant or award | +20,328 | 125,218 | ||
| 2025-02-04 | Bozic Carmen EVP and CMO | Grant or award | +10,262 | 33,521 | ||
| 2025-02-04 | Bozic Carmen EVP and CMO | Grant or award | +5,928 | 39,449 | ||
| 2025-02-04 | Biller Jonathan EVP and Chief Legal Officer | Grant or award | +4,744 | 21,395 | ||
| 2025-02-04 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Grant or award | +5,132 | 21,104 | ||
| 2025-02-04 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Grant or award | +4,744 | 25,848 | ||
| 2025-02-04 | Arbuckle Stuart A EVP, COO | Grant or award | +14,624 | 64,315 | ||
| 2025-02-04 | Arbuckle Stuart A EVP, COO | Grant or award | +8,448 | 72,763 |
Page 17 of 18 · 344 trades